New Zealand markets closed

Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
267.91+4.75 (+1.80%)
At close: 04:00PM EDT
264.81 -3.10 (-1.16%)
After hours: 05:16PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 38.02B
Enterprise value 39.74B
Trailing P/E 12.71
Forward P/E 17.12
PEG ratio (5-yr expected) 3.04
Price/sales (ttm)3.81
Price/book (mrq)2.86
Enterprise value/revenue 3.91
Enterprise value/EBITDA 9.12

Trading information

Stock price history

Beta (5Y monthly) 0.19
52-week change 327.02%
S&P500 52-week change 3-12.41%
52-week high 3311.88
52-week low 3187.16
50-day moving average 3278.20
200-day moving average 3250.77

Share statistics

Avg vol (3-month) 3998.12k
Avg vol (10-day) 3941.99k
Shares outstanding 5144.49M
Implied shares outstanding 6N/A
Float 8144.06M
% held by insiders 10.69%
% held by institutions 189.91%
Shares short (27 Feb 2023) 41.85M
Short ratio (27 Feb 2023) 42.04
Short % of float (27 Feb 2023) 41.45%
Short % of shares outstanding (27 Feb 2023) 41.28%
Shares short (prior month 30 Jan 2023) 41.87M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 23:1
Last split date 317 Jan 2001

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Dec 2022


Profit margin 29.95%
Operating margin (ttm)29.63%

Management effectiveness

Return on assets (ttm)7.78%
Return on equity (ttm)24.33%

Income statement

Revenue (ttm)10.17B
Revenue per share (ttm)70.02
Quarterly revenue growth (yoy)-6.90%
Gross profit (ttm)7.9B
Net income avi to common (ttm)3.05B
Diluted EPS (ttm)20.71
Quarterly earnings growth (yoy)49.50%

Balance sheet

Total cash (mrq)4.89B
Total cash per share (mrq)33.86
Total debt (mrq)6.71B
Total debt/equity (mrq)50.13
Current ratio (mrq)2.99
Book value per share (mrq)92.98

Cash flow statement

Operating cash flow (ttm)1.38B
Levered free cash flow (ttm)1.39B